Navigation Links
Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011
Date:2/3/2011

" "expect," and similar expressions, as they relate to the Company, constitute forward-looking statements. Actual results may differ materially from those reflected in these forward-looking statements due to various factors, including further evaluation of clinical data, results of clinical trials, the performance of third-party service providers, decisions by regulatory authorities regarding whether or when to proceed to the next phase of clinical trials, general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries and those discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2009 under the heading "Risk Factors," and in Auxilium's Quarterly Report on Form 10-Q for the period ended September 30, 2010, which are on file with the Securities and Exchange Commission (the "SEC") and may be accessed electronically by means of the SEC's home page on the Internet at http://www.sec.gov or by means of the Company's home page on the Internet at http://www.auxilium.com under the heading "For Investors -- SEC Filings." There may be additional risks that the Company does not presently know or that the Company currently believes are immaterial which could also cause actual results to differ from those contained in forward-looking statements. Given these risks and uncertainties, any or all of the forward-looking statements contained in this release may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements.

In addition, forward-looking statements provide the Company's expectations, plans or forecasts of future events and views as of the date of this release. The Company anticipates that subsequent events and developments will cause the Company's assessments to change. However, while the Company may elect to update these forward-looking statements at some point i
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vanda Pharmaceuticals to Announce Fourth Quarter 2010 Financial Results on February 10, 2011
2. Onyx Pharmaceuticals Receives Fast Track Designation for Carfilzomib; Company Initiates Rolling NDA Submission for Accelerated Approval
3. Cadence Pharmaceuticals Announces U.S. Launch and Availability of OFIRMEV™ (acetaminophen) Injection
4. Cempra Pharmaceuticals Profiles the Broad Spectrum and Potent Activity Profile of Solithromycin (CEM-101) at the 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day
5. Takeda and Zinfandel Pharmaceuticals Sign Licensing Agreement for Alzheimers Disease Biomarker in Combination with Pioglitazone
6. Savient Pharmaceuticals Provides Business Update
7. Anthera Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
8. Anadys Pharmaceuticals Augments Management Team and Board of Directors
9. Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline
10. Onyx Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
11. Keryx Biopharmaceuticals to Present at 29th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... CROWN POINT, Ind. , July 10, ... recently expanded its use of capnography for ... a growing group of healthcare leaders in ... Capnography measures how effectively patients are breathing ... respiratory depression occurs. By measuring the amount ...
(Date:7/10/2014)... OAKS, Calif., July 10, 2014   Ceres, Inc ... and seed company, announced today financial results for the ... update on its business. Ceres reported that ... in product performance this growing season in Brazil, which ... affected the company,s sorghum evaluation areas for part of ...
(Date:7/10/2014)... disorders has been extremely challenging because there are many ... to cause disease. Now investigators reporting in the July ... Stem Cell describe a strategy that may help ... risk factors or environmental exposures to affect the development ... variant that may predispose individuals to schizophrenia. , ...
(Date:7/10/2014)... the University of Illinois at Urbana-Champaign provides new ... of spin and heat at the nanoscale, and ... for data storage and information processing. , ... momentum. In a typical charge current, electrons, spin-angular-momentum ... explained David Cahill, a professor of materials science ...
Breaking Biology Technology:Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9New strategy could uncover genes at the root of psychiatric illnesses 2University of Illinois study advances limits for ultrafast nano-devices 2
... As evidence of its drive to return ... Smith & Nephew ( SNN, LSE: SN) Orthopaedics Division ... VERILAST technology for knee replacement implants. After simulating 30 ... replacement, VERILAST technology produced an 81-percent reduction* in wear, ...
... ... ... 2010 -- Therapeutic Proteins Inc. (TPI) today announced the completion of the ... Food and Drug Administration (FDA) requirements. The Chicago facility is located at University ...
... ... is designed to purify DNA from whole blood. , ... (PRWEB) April 21, 2010 -- Promega Corporation now offers the ... blood. The new kit, optimized to work on the Maxwell® 16 instrument, eliminates the need ...
Cached Biology Technology:Smith & Nephew Receives FDA 510k Clearance for a 30-year Knee 2Smith & Nephew Receives FDA 510k Clearance for a 30-year Knee 3Smith & Nephew Receives FDA 510k Clearance for a 30-year Knee 4Smith & Nephew Receives FDA 510k Clearance for a 30-year Knee 5Therapeutic Proteins Inc. Completes First Independent, Dedicated Biosimilars Manufacturing Facility in U.S. 2Therapeutic Proteins Inc. Completes First Independent, Dedicated Biosimilars Manufacturing Facility in U.S. 3Therapeutic Proteins Inc. Completes First Independent, Dedicated Biosimilars Manufacturing Facility in U.S. 4New Promega Maxwell 16 LEV Blood DNA Kit Surpasses Concentration Standards in Less Time 2
(Date:7/10/2014)... Axinaea belongs to the large, mainly tropical flowering ... 5000 species in the family rely on bees for their ... other insects or vertebrates. The flowers of Axinaea ... and the petals of the different species are pink, yellow, ... based on the contrasting colours of their bulbous appendages. The ...
(Date:7/10/2014)... in your popcorn or soap might not be ape friendly, ... to an analysis in the Cell Press journal Current ... vegetable oil has already led to the conversion of Southeast ... in particular. If guidelines are not put in place very ... from Asia into Africa will be bad news for great ...
(Date:7/10/2014)... Decades of overfishing in the English Channel has resulted ... sea and left fishermen ,scraping the barrel, for increasing ... rays, cod, haddock and many other species at the ... with many removed from the area completely., These are ... marine biologists at Plymouth University, in association with international ...
Breaking Biology News(10 mins):Novel type of bird pollination mechanism discovered in South America 2Hunger for vegetable oil means trouble for Africa's great apes 2Overfishing in the English Channel leaves fisherman scraping the bottom of the barrel 2Overfishing in the English Channel leaves fisherman scraping the bottom of the barrel 3
... University of York have discovered a ,Chemical Equator, that ... the largely uncontaminated atmosphere of the Southern Hemisphere. ... for an atmospheric chemical equator around 50 km wide ... show for the first time that the chemical and ...
... to investigate the biological causes of the second most ... prestigious 1.9 million senior fellowship award from the Medical ... group of dementias that affect the frontal and temporal ... and language dysfunction, rather than the memory loss associated ...
... an excess of sexual steroids, like testosterone, during fetal ... sperm count and motility, according to a new study ... of The Endocrine Society. "The majority of disorders ... life," said Professor Sergio Recabarren of the University of ...
Cached Biology News:'Chemical equator' discovery will aid pollution mapping 2£2 million study to reveal workings of dementia genes 2Low sperm count may be associated with prenatal testosterone excess 2
Topoisomerase I, isolated from wheat germ, is an enzyme capable of removing negative supercoils from covalently closed circular DNA (1)....
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5...
... Accession Number : NM_006225 Immunogen : ... corresponding to full length rat PLC delta ... NaCl, 0.05% sodium azide before the addition ... evaluated by immunoblot on RIPA lysates from ...
Request Info...
Biology Products: